Barry Bloom


Barry R. Bloom is an American immunologist known for his research on the immune response to infectious diseases, including tuberculosis, leprosy, malaria, and COVID-19. He is the Joan L. and Julius H. Jacobson Professor of Public Health, Emeritus in the Department of Immunology and Infectious Diseases and the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health, where he served as dean of the faculty from 1998 through 2008.

Early life and education

Bloom has stated that the influence of the numerous physicians in his family led him to expect a medical career, before choosing immunology research instead.
From 1978 to 1990, Bloom was chairman of the Department of Microbiology and Immunology at the Albert Einstein College of Medicine. In 1990, he became an investigator of the Howard Hughes Medical Institute, also serving on its national advisory board. In 1978 he acted as a consultant to the White House on international health policy.
As dean of the Harvard School of Public Health, Bloom also served as secretary-treasurer of the Association of Schools of Public Health. He has held faculty appointments in the Departments of Immunology and Infectious Diseases and of Global Health and Population.

Research contributions

Bloom has been a leading scientist in immunology and global health. Much of his laboratory research has focused on host immune responses to Mycobacterium tuberculosis, defining vitamin D-dependent antimicrobial mechanisms in macrophages and developing aerosolized nanoparticle vaccine approaches.
He chaired the WHO Technical and Research Advisory Committee to the Global Programme on Malaria, contributing to international strategies for malaria control and vaccine research. He also chaired WHO committees on leprosy and tuberculosis research, and served on the Scientific and Technical Advisory Committee of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
During the COVID-19 pandemic, Bloom provided expert analysis on vaccines and public health policy in national media and at Harvard press conferences. In 2020 he was appointed to the Massachusetts state advisory committee on coronavirus vaccines.

Policy and advisory roles

Bloom has been involved with the World Health Organization for more than four decades, serving on multiple advisory committees. He was the founding chair of the board of trustees for the International Vaccine Institute in South Korea, chaired the Vaccine Advisory Committee of UNAIDS, and was a member of the U.S. AIDS Research Committee. He has served on scientific advisory boards for the Ellison Medical Foundation, the Wellcome Trust, the Earth Institute at Columbia University, and the Paul G. Rogers Society for Global Health Research.

Selected publications

  • Bloom BR, Bennett B. "Mechanism of a reaction in vitro associated with delayed-type hypersensitivity." Science. 1966;153:80–82.
  • Modlin RL, Bloom BR. "Immunologic mechanisms in leprosy." Annual Review of Immunology. 1984;2:41–60.
  • Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. "Toll-like receptor triggering of a vitamin D–mediated human antimicrobial response." Science. 2006;311:1770–1773.
A more complete list of publications is available at .

Awards and honors